Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Cited by (1,001)

Items 101–200 of 1,001

1. Strength of PD-1 signaling differentially affects T-cell effector functions
   Fang Wei, Shi Zhong, Zhengyu Ma, Hong Kong, Andrew R. Medvec, Rafi Ahmed, Gordon James Freeman, Michelle Krogsgaard, James L. Riley · 2013 · Proceedings of the National Academy of Sciences
2. CD8+ T cells in HIV control, cure and prevention
   David R. Collins, Gaurav D. Gaiha, Bruce D. Walker · 2020 · Nature reviews. Immunology
3. Role of PD-1 in Regulating T-Cell Immunity
   Hyun‐Tak Jin, Rafi Ahmed, Taku Okazaki · 2010 · Current topics in microbiology and immunology
4. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
   Pavan Brahmamdam, Shigeaki Inoue, Jacqueline Unsinger, Katherine C. Chang, Jonathan E. McDunn, Richard S. Hotchkiss · 2010 · Journal of Leukocyte Biology
5. Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
   Jeffrey S. Weber · 2010 · Seminars in Oncology
6. Memory Inflation during Chronic Viral Infection Is Maintained by Continuous Production of Short-Lived, Functional T Cells
   Christopher M. Snyder, Kathy S. Cho, Elizabeth L. Bonnett, Serani L.H. van Dommelen, GEOFFREY R. SHELLAM, Ann B. Hill · 2008 · Immunity
7. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors
   Ji‐Yuan Zhang, Zheng Zhang, Xicheng Wang, Junliang Fu, Jinxia Yao, Yanmei Jiao, Liangen Chen, Hui Zhang, Jianan Wei, Lei Jin et al. · 2007 · Blood
8. Features of responding T cells in cancer and chronic infection
   Peter S. Kim, Rafi Ahmed · 2010 · Current Opinion in Immunology
9. Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization
   Nobuhiro Nakamoto, David Edward Kaplan, Jennifer Coleclough, Yun Li, Mary E. Valiga, Mary Kaminski, Abraham A. Shaked, Kim Marie Olthoff, Emma Gostick D, David A. Price et al. · 2008 · Gastroenterology
10. T-bet and Eomes Are Differentially Linked to the Exhausted Phenotype of CD8+ T Cells in HIV Infection
    Marcus Buggert, Johanna Tauriainen, Takuya Yamamoto, Juliet Frederiksen, Martin A. Ivarsson, Jakob Michaëlsson, Ole Lund, Bo Hejdeman, Marianne Jansson, Anders B. Sönnerborg et al. · 2014 · PLoS Pathogens
11. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
    Erin E. West, Hyun‐Tak Jin, Ata Ur Rasheed, Pablo Penaloza‐MacMaster, Sang‐Jun Ha, Wendy G. Tan, Ben Youngblood, Gordon James Freeman, Kendall A. Smith, Rafi Ahmed · 2013 · Journal of Clinical Investigation
12. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
    Christine Katlama, Steven G. Deeks, Brigitte Autran, Javier Martínez‐Picado, Jan van Lunzen, Christine Rouzioux, Michael D. Miller, Stefano Vella, Jörn E. Schmitz, Jeffrey D. Ahlers et al. · 2013 · The Lancet
13. Chronic Exposure to Plasmodium falciparum Is Associated with Phenotypic Evidence of B and T Cell Exhaustion
    Joseph J. Illingworth, Noah S. Butler, Sophie Roetynck, Jedida Mwacharo, Susan K. Pierce, Philip Bejon, Peter D. Crompton, Kevin Marsh, Francis Maina Ndungu · 2012 · The Journal of Immunology
14. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection
    Amalia Penna, Massimo Pilli, Alessandro Zerbini, Alessandra Orlandini, Sergio Mezzadri, Luca Sacchelli, Gabriele Missale, Carlo I. Ferrari · 2007 · Hepatology
15. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
    Adriano Boasso, Jean‐Philippe Herbeuval, Andrew W. Hardy, Stephanie A. Anderson, Matthew J. Dolan, Dietmar Fuchs, Gene M. Shearer · 2006 · Blood
16. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells
    Mark A. Brockman, Douglas S. Kwon, Daniel P. Tighe, David F. Pavlik, Pamela C. Rosato, Jennifer Sela, Filippos Porichis, Sylvie Le Gall, Michael T. Waring, Kristin Moss et al. · 2009 · Blood
17. Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice
    Diana M. Brainard, Edward Seung, Nicole Frahm, Annaiah Cariappa, Charles C. Bailey, William K. Hart, Hae‐Sook Shin, Sarah F. Brooks, Heather Knight, Quentin G. Eichbaum et al. · 2009 · Journal of Virology
18. The growth and potential of human antiviral monoclonal antibody therapeutics
    Wayne Anthony Marasco, Jianhua Sui · 2007 · Nature Biotechnology
19. PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
    Jacalyn M. Rosenblatt, Brett E. Glotzbecker, Heidi Mills, Baldev Vasir, Dimitrios Tzachanis, James D. Levine, Robin Joyce, Kerry Wellenstein, Whitney Keefe, Michael Schickler et al. · 2011 · Journal of Immunotherapy
20. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion
    Daniel T. Utzschneider, Amandine Legat, Silvia A. Fuertes Marraco, Lucie Carrié, Immanuel F. Luescher, Daniel E. Speiser, Dietmar Zehn · 2013 · Nature Immunology
21. B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy
    Susan L. Moir, Clarisa M. Buckner, Jason Ho, Wei Wang, Jenny Chen, Amy J. Waldner, Jacqueline G. Posada, Lela Kardava, Marie A. O’Shea, Shyam Kottilil et al. · 2010 · Blood
22. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
    Wenshi Wang, Roy Lau, Daohai Yu, Weiwei Zhu, Alan J. Korman, Jeffrey S. Weber · 2009 · International Immunology
23. HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
    Didier Trono, Carine M. Van Lint, Christine Rouzioux, Eric M. Verdin, Françoise Barré‐Sinoussi, Tae‐Wook Chun, Nicolas Chomont · 2010 · Science
24. The Importance of Dendritic Cells in Maintaining Immune Tolerance
    Cindy Audiger, Muhammad Jubayer Rahman, Tae Jin Yun, Kristin V. Tarbell, Sylvie Lesage · 2017 · The Journal of Immunology
25. The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
    Günther Schönrich, Martin J. Raftery · 2019 · Frontiers in Cellular and Infection Microbiology
26. Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
    M. Juliana McElrath, Barton F. Haynes · 2010 · Immunity
27. PD-1 deficiency results in the development of fatal myocarditis in MRL mice
    Jian Wang, Il‐mi Okazaki, Taku Yoshida, Shunsuke Chikuma, Yu Kato, Fumio Nakaki, Hiroshi Hiai, Tasuku Honjo, Taku Okazaki · 2010 · International Immunology
28. Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated with T Cell Dysfunction
    Michelle D’Souza, Andrew P. Fontenot, Doug G. Mack, Catherine Lozupone, Stephanie M. Dillon, Amie L. Meditz, Cara C. Wilson, Elizabeth Connick, Brent E. Palmer · 2007 · The Journal of Immunology
29. Cell-Intrinsic Transforming Growth Factor-β Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence In Vivo
    Roberto Tinoco, Víctor Alcalde, Yating Yang, Karsten Sauer, Elina I. Zúñiga · 2009 · Immunity
30. Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation
    De-xiu Bu, Margarite L. Tarrio, Elena Maganto-García, George Stavrakis, Goro Tajima, James Arthur Lederer, Petr Jarolı́m, Gordon James Freeman, Arlene H. Sharpe, Andrew H. Lichtman · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
31. Emerging Tim-3 functions in antimicrobial and tumor immunity
    Kaori Sakuishi, Pushpa Jayaraman, Samuel M. Behar, Ana Carrizosa Anderson, Vijay Kumar Kuchroo · 2011 · Trends in Immunology
32. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
    Yan Zhang, Jinbao Li, Jingsheng Lou, Ying Zhou, Lulong Bo, Jiali Zhu, Keming Zhu, Xiaojian Wan, Zailong Cai, Xiaoming Deng · 2011 · Critical Care
33. Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis
    Javier O. Jurado, Ivana B. Alvarez, Virginia Pasquinelli, Gustavo Martínez, María Florencia Quiroga, Eduardo H Abbate, Rosa María Musella, Eduardo Chuluyán, Verónica García · 2008 · The Journal of Immunology
34. Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
    John Attanasio, E. John Wherry · 2016 · Immunity
35. Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1
    Kiyoshi Hirahara, Kamran Ghoreschi, Xiang‐Ping Yang, Hayato Takahashi, Arian D. J. Laurence, Golnaz Vahedi, Giuseppe Sciumè, Aisling O’Hara Hall, Christopher D. Dupont, Loise M. Francisco et al. · 2012 · Immunity
36. Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
    Jia Liu, Ejuan Zhang, Zhiyong Ma, Weimin Wu, Anna D. Kosinska, Xiaoyong Zhang, Inga Möller, Pia L. Seiz, Dieter Glebe, Baoju Wang et al. · 2014 · PLoS Pathogens
37. Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells
    Hiroyu Hatano, Vivek Jain, Peter W. Hunt, Tzong‐Hae Lee, Elizabeth Sinclair, Tri Do, Rebecca Hoh, Jeffrey N. Martin, J M McCune, Frederick M. Hecht et al. · 2012 · The Journal of Infectious Diseases
38. Phenotype, Function, and Gene Expression Profiles of Programmed Death-1hi CD8 T Cells in Healthy Human Adults
    Jaikumar Duraiswamy, Chris Ibegbu, David Masopust, Joseph D Miller, Koichi Araki, Gregory Doho, Pramila Tata, Gupta Sk, Michael J. Zilliox, Helder Imoto Nakaya et al. · 2011 · The Journal of Immunology
39. Genetic and Epigenetic Regulation of PD-1 Expression
    Alexander P. R. Bally, James W Austin, Jeremy M. Boss · 2016 · The Journal of Immunology
40. Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
    Yan Zhang, Shengdong Huang, Dejun Gong, Yanghua Qin, Qian Shen · 2010 · Cellular and Molecular Immunology
41. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice
    Israel Gotsman, Nir Grabie, Rosa DaCosta, Galina K. Sukhova, Arlene H. Sharpe, Andrew H. Lichtman · 2007 · Journal of Clinical Investigation
42. PD-1 Regulates Self-Reactive CD8+ T Cell Responses to Antigen in Lymph Nodes and Tissues
    Mary E Keir, Gordon James Freeman, Arlene H. Sharpe · 2007 · The Journal of Immunology
43. Cytomegalovirus Infection: A Driving Force in Human T Cell Immunosenescence
    KOCH, SVEN, LARBI, ANIS, ÖZCELIK, DENNIS, SOLANA, RAFAEL, GOUTTEFANGEAS, CÉCILE, ATTIG, SEBASTIAN, WIKBY, ANDERS, STRINDHALL, JAN, FRANCESCHI, CLAUDIO, PAWELEC, GRAHAM · 2007 · Annals of the New York Academy of Sciences
44. Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells
    Hendrik Streeck, Zabrina L. Brumme, Michael P. Anastario, Kristin W. Cohen, Jonathan S. Jolin, Angela Meier, Chanson J. Brumme, Eric S. Rosenberg, Galit Alter, Todd M. Allen et al. · 2008 · PLoS Medicine
45. Tuberculosis biomarkers discovery: developments, needs, and challenges
    Robert S. Wallis, Peter S. Kim, Stewart Thomas Cole, Debra L. Hanna, Bruno B. Andrade, Markus J. Maeurer, Marco L. Schito, Alimuddin I. Zumla · 2013 · The Lancet Infectious Diseases
46. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy
    Fumihiko Tsushima, Sheng Yao, Tahiro Shin, Andrew S. Flies, Sarah J. Flies, Haiying Xu, Koji Tamada, Drew M. Pardoll, Lieping Chen · 2007 · Blood
47. Influence of Inflammation in the Process of T Lymphocyte Differentiation: Proliferative, Metabolic, and Oxidative Changes
    Marco Antonio Moro‐García, Juan C. Mayo, Rosa María Sainz, Rebeca Alonso‐Arias · 2018 · Frontiers in Immunology
48. A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
    David Gardiner, Jacob Paul Lalezari, Eric Lawitz, Michael DiMicco, Rheem Ghalib, K. Rajender Reddy, Kyong‐Mi Chang, Mark Sulkowski, Steven O’ Marro, Jeffrey Anderson et al. · 2013 · PLoS ONE
49. Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
    Takashi Inozume, Ken‐ichi Hanada, Qiong J. Wang, Mojgan Ahmadzadeh, John R. Wunderlich, Steven A. Rosenberg, James Chih-Hsin Yang · 2010 · Journal of Immunotherapy
50. PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
    DE Kaufmann, Bruce D. Walker · 2009 · The Journal of Immunology
51. Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
    R. M. S. Wong, Ronaldo Scotland, Roy Lau, Chenhui Wang, Alan J. Korman, W. Martin Kast, Jeffrey S. Weber · 2007 · International Immunology
52. Interaction of human PD-L1 and B7-1
    Manish J. Butte, Victor Peña‐Cruz, Mi‐Jung Kim, Gordon James Freeman, Arlene H. Sharpe · 2008 · Molecular Immunology
53. CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV‐positive patients
    Wei Lu, Vikram Mehraj, Kishanda Vyboh, Wei Cao, Taisheng Li, Jean‐Pierre Routy · 2015 · Journal of the International AIDS Society
54. Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
    Cynthia L. Gay, Ronald J. Bosch, Justin Ritz, Jason M. Hataye, Evgenia Aga, Randall L. Tressler, Stephen W. Mason, Carey K. Hwang, Dennis M. Grasela, Neelanjana Ray et al. · 2017 · The Journal of Infectious Diseases
55. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
    John Frater, Katie Ewer, Ane Ogbe, Mathew Pace, Sandra Adele, Emily Adland, Jasmini Alagaratnam, Parvinder K. Aley, Mohammad Ali, M. Azim Ansari et al. · 2021 · The Lancet HIV
56. The loss of telomerase activity in highly differentiated CD8+CD28−CD27− T cells is associated with decreased Akt (Ser473) phosphorylation
    Plunkett, Fiona J, Franzese, Ornella, Finney, Helene M, Fletcher, Jean M, Belaramani, Lavina L, Salmon, Mike, Dokal, Inderjeet, Webster, David, Lawson, Alastair D G, Akbar, Arne N · 2007 · The Journal of Immunology
57. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients
    Guoping Peng, Shuping Li, Wei Wu, Xufei Tan, Yiqiong Chen, Zhi Chen · 2007 · Molecular Immunology
58. IL-10, T cell exhaustion and viral persistence
    Shawn D. Blackburn, E. John Wherry · 2007 · Trends in Microbiology
59. Immunopathogenesis of hepatitis B virus infection
    J. Judy Chang, Sharon R. Lewin · 2006 · Immunology and Cell Biology
60. Revisiting Immune Exhaustion During HIV Infection
    Alka Khaitan, Derya Unutmaz · 2010 · Current HIV/AIDS Reports
61. Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection
    Sang‐Jun Ha, Scott N. Mueller, E. John Wherry, Daniel L. Barber, Rachael D. Aubert, Arlene H. Sharpe, Gordon James Freeman, Rafi Ahmed · 2008 · The Journal of Experimental Medicine
62. Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
    Ping Yu, Jason C. Steel, Meili Zhang, John Charles Morris, Thomas A. Waldmann · 2010 · Clinical Cancer Research
63. CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions
    SA Phillips, Shilpa Chokshi, Antonio Riva, Alexander Evans, Roger L. Williams, Nikolai V. Naoumov · 2009 · The Journal of Immunology
64. PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals
    Rémi Fromentin, Sandrina DaFonseca, Cecilia Theresa Costiniuk, Mohamed El Far, Francesco A. Procopio, Frederick M. Hecht, Rebecca Hoh, Steven G. Deeks, Daria J. Hazuda, Sharon R. Lewin et al. · 2019 · Nature Communications
65. Plasticity in programming of effector and memory CD8+ T‐cell formation
    Ramon Arens, Stephen Philip Schoenberger · 2010 · Immunological Reviews
66. PD-1 on dendritic cells impedes innate immunity against bacterial infection
    Sheng Yao, Shengdian Wang, Yuwen Zhu, Liqun Luo, Gefeng Zhu, Sarah J. Flies, Haiying Xu, William E. Ruff, Megan Broadwater, In-Hak Choi et al. · 2009 · Blood
67. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis
    Adriano Boasso, Gene M. Shearer · 2007 · Clinical Immunology
68. Viral acute lower respiratory infections impair CD8+ T cells through PD-1
    Erickson, John J., Gilchuk, Pavlo, Hastings, Andrew K., Tollefson, Sharon J., Johnson, Monika, Downing, Melissa B., Boyd, Kelli L., Johnson, Joyce E., Kim, Annette S., Joyce, Sebastian et al. · 2012 · Journal of Clinical Investigation
69. An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
    Chen Ying Zhu, Kaori Sakuishi, Sheng Xiao, Zhiyi Sun, Sarah Zaghouani, Guangxiang Gu, Chao Wang, Dewar J. Tan, Chuan Wu, Manu Rangachari et al. · 2015 · Nature Communications
70. PD-1 regulates KLRG1+ group 2 innate lymphoid cells
    Samuel R. Taylor, Yuefeng Huang, Grace Mallett, Chaido Stathopoulou, Tania C. Felizardo, Ming‐an Sun, Evelyn L. Martin, Nathaniel Zhu, Emma L. Woodward, Martina S. Elias et al. · 2017 · The Journal of Experimental Medicine
71. Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
    Tsvetelina Pentcheva‐Hoang, Emily Corse, James Patrick Allison · 2009 · Immunological Reviews
72. High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8 + and CD4 + T Cells during Acute HCV Infection, Irrespective of Clinical Outcome
    Victoria O Kasprowicz, Julian Schulze zur Wiesch, Thomas Kuntzen, Brian E. Nolan, Steven Longworth, Andrew C. Berical, Jenna Blum, Cory M. McMahon, Laura L. Reyor, Nahel Elias et al. · 2007 · Journal of Virology
73. Defective Human Immunodeficiency Virus-Specific CD8 + T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
    Stephen A. Migueles, Kristin A. Weeks, Eric Nou, Amy M. Berkley, Julia E. Rood, Christine M. Osborne, Claire W. Hallahan, Nancy A. Cogliano-Shutta, Julia A. Metcalf, Mary E. McLaughlin et al. · 2009 · Journal of Virology
74. IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
    Zhaojun Sun, Julien J. Fourcade, Ornella Pagliano, Joë-Marc Chauvin, Cindy Sander, John M. Kirkwood, Hassane M. Zarour · 2015 · Cancer Research
75. An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
    Guillaume Mousseau, Mark A. Clementz, Wendy Bakeman, Nisha Nagarsheth, Michael D. Cameron, Jun Shi, Phil S. Baran, Rémi Fromentin, Nicolas Chomont, Susana T. Valente · 2012 · Cell Host & Microbe
76. PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
    Vrajesh V. Parekh, Saif Lalani, Sungjune Kim, Ramesh Chandra Halder, Miyuki Azuma, Hideo Yagita∥, Vipin Kumar, Lan Wu, Luc Van Kaer · 2009 · The Journal of Immunology
77. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection
    Takuya Yamamoto, David A. Price, Joseph P. Casazza, Guido Ferrari, Martha Nason, Pratip K. Chattopadhyay, Mario Roederer, Emma Gostick D, Peter D. Katsikis, Daniel C. Douek et al. · 2011 · Blood
78. Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors
    Betty Li, Melinda J. VanRoey, Changyu Wang, Tseng-hui Timothy Chen, Alan J. Korman, Karin U. Jooss · 2009 · Clinical Cancer Research
79. Taming cancer by inducing immunity via dendritic cells
    Anna Karolina Palucka, Hideki Ueno, Joseph W. Fay, Jacques Banchereau · 2007 · Immunological Reviews
80. The Immune Response to Human CMV
    Corinna La Rosa, Don J. Diamond · 2012 · Future Virology
81. The impact of differential antiviral immunity in children and adults
    Andrew J. Prendergast, Paul Klenerman, Philip Goulder · 2012 · Nature reviews. Immunology
82. HIV-1-Specific Interleukin-21 + CD4 + T Cell Responses Contribute to Durable Viral Control through the Modulation of HIV-Specific CD8 + T Cell Function
    Mathieu F. Chevalier, Boris Dominik Jülg, Augustine Pyo, Michael Flanders, Srin Ranasinghe, Damien Z. Soghoian, Douglas S. Kwon, Jenna A. Rychert, Jeffrey Lian, Matthias I. Muller et al. · 2010 · Journal of Virology
83. The T-Cell Response to HIV
    Bruce D. Walker, A J McMichael · 2012 · Cold Spring Harbor Perspectives in Medicine
84. Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion
    Christine M. Bucks, Jillian Norton, Alina C. Boesteanu, Yvonne M. Mueller, Peter D. Katsikis · 2009 · The Journal of Immunology
85. PD-1 expression on dendritic cells suppresses CD8⁺T cell function and antitumor immunity
    Lim, Tong Seng, Chew, Valerie, Sieow, Je Lin, Goh, Siting, Yeong, Joe Poh-Sheng, Soon, Ai Ling, Ricciardi-Castagnoli, Paola · 2016 · OncoImmunology
86. Innate immune recognition and activation during HIV infection
    Trine Hyrup Mogensen, Jesper Melchjorsen, Carsten Schade Larsen, Søren R. Paludan · 2010 · Retrovirology
87. Humanized mouse models to study human diseases
    Michael A. Brehm, Leonard D. Shultz, Dale L. Greiner · 2010 · Current Opinion in Endocrinology Diabetes and Obesity
88. Early Resolution of Acute Immune Activation and Induction of PD-1 in SIV-Infected Sooty Mangabeys Distinguishes Nonpathogenic from Pathogenic Infection in Rhesus Macaques
    Jacob D. Estes, Shari N. Gordon, Ming Zeng, Ann Chahroudi, Richard M. Dunham, Silvija I. Staprans, Cavan Reilly, Guido Silvestri, Ashley T. Haase · 2008 · The Journal of Immunology
89. Circulating CXCR5+PD-1+ Response Predicts Influenza Vaccine Antibody Responses in Young Adults but not Elderly Adults
    Herati, Ramin Sedaghat, Reuter, Morgan A, Dolfi, Douglas V, Mansfield, Kathleen D, Aung, Htin, Badwan, Osama Z, Kurupati, Raj K, Kannan, Senthil, Ertl, Hildegund, Schmader, Kenneth E et al. · 2014 · The Journal of Immunology
90. The Role of IL-10 in Regulating Immunity to Persistent Viral Infections
    Elizabeth B. Wilson, David G. Brooks · 2010 · Current topics in microbiology and immunology
91. HIV pathogenesis: 25 years of progress and persistent challenges
    Jay A. Levy · 2008 · AIDS
92. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
    Tomohiro Kozako, Makoto Yoshimitsu, Hiroshi Fujiwara, Izumi Masamoto, Sawako Horai, Yohann White, Masaki Akimoto, Susumu Suzuki, Kazuyuki Matsushita, K Uozumi et al. · 2008 · Leukemia
93. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells
    Szu-Han Huang, Yanqin Ren, Allison S. Thomas, Dora Chan, Stefanie Mueller, Adam R. Ward, Shabnum Patel, Catherine M. Bollard, Carolina Colli Cruz, Sara Karandish et al. · 2018 · Journal of Clinical Investigation
94. The immune mechanisms of abscopal effect in radiation therapy
    George Daniel Grass, Niveditha Krishna, Sungjune Kim · 2015 · Current Problems in Cancer
95. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status
    Delphine Sauce, Jorge R. Almeida, Martin Larsen, Laurine Haro, Brigitte Autran, Gordon James Freeman, Victor Appay · 2007 · AIDS
96. Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
    Hiroyu Hatano, Matthew C. Strain, Rebecca Scherzer, Peter Bacchetti, Deborah N. Wentworth, Rebecca Hoh, Jeffrey N. Martin, J M McCune, James D. Neaton, Russell P. Tracy et al. · 2013 · The Journal of Infectious Diseases
97. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection
    Constantinos Petrovas, David A. Price, Joseph J. Mattapallil, David R. Ambrozak, Christof Geldmacher, Valentina Cecchinato, Monica Vaccari, Elżbieta Anna Tryniszewska, Emma Gostick D, Mario Roederer et al. · 2007 · Blood
98. Dynamic Programmed Death 1 Expression by Virus-Specific CD8 T Cells Correlates With the Outcome of Acute Hepatitis B
    Zheng Zhang, Ji‐Yuan Zhang, E. John Wherry, Bo Jin, Bin Xu, Zhengsheng Zou, Shu–Ye Zhang, Baosen Li, Hui–Feng Wang, Hao Wu et al. · 2008 · Gastroenterology
99. Coinfection With HIV-1 and HCV—A One-Two Punch
    Arthur Y. Kim, Raymond T. Chung · 2009 · Gastroenterology
100. Immunology and the elusive AIDS vaccine
     Herbert W. Virgin, Bruce D. Walker · 2010 · Nature